HHS Launches Plan to Address Overprescribing of Psychiatric Medications U.S. Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a federal initiative Monday aimed at curbing the overprescription of psychiatric medications and promoting alternative treatments. The plan, announced at the MAHA Institute summit on mental health and overmedicalization, emphasizes patient autonomy, informed consent, and a shift toward holistic care. Kennedy framed the effort as a critical step in addressing the nation’s mental health crisis, particularly among children, by reducing reliance on psychiatric drugs and prioritizing prevention and transparency. The initiative follows recent advocacy by mental health professionals, including guidelines from the American Society of Clinical Psychopharmacology published in February, which outline criteria for evaluating when discontinuation of medications is appropriate. While some experts welcomed the federal push for improved psychiatric care, they also raised concerns about potential overemphasis on overprescribing amid existing gaps in mental health access. Kennedy’s efforts are part of his broader “Make America Healthy Again” movement, which has targeted psychiatric medications since his appointment last year. He has claimed these drugs are overused and linked to risks such as violence, mass shootings, fetal harm during pregnancy, severe withdrawal symptoms, and adverse effects on children. However, the U.S. Food and Drug Administration has consistently deemed antidepressants and other psychiatric medications safe and effective for conditions like depression, anxiety, eating disorders, and obsessive-compulsive disorder.#robert_f_kennedy_jr #hhs #maha_institute_summit #american_society_of_clinical_psychopharmacology #american_psychiatric_association
